Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Talzenna 1 mg hard capsules
Disc Medicine
Breast cancer
1 trial -
Tetanusvaccin, suspensie voor injectie 40 IE
Disc Medicine
Systemic sclerosis, Systemic lupus erythematosus, Rheumatoid arthritis
1 trial -
Ultomiris 300 mg/30 mL concentrate for solution for infusion
Disc Medicine
Paroxysmal nocturnal hemoglobinuria (PNH)
1 trial -
VENLAFAXINE
Disc Medicine
Major Depressive Disorder
1 trial -
Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geΓ―nactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)
Disc Medicine
healthy individuals
1 trial -
Vitamine E-400 complex, Microgynon 30, 0,15 mg/0,03 mg omhulde tabletten
Disc Medicine
Migraine
1 trial -
XELJANZ 11 mg prolonged-release tablets
Disc Medicine
Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria
1 trial -
Xolair 150 mg solution for injection in pre-filled syringe, Physiological saline
Disc Medicine
Carotid artery stenosis
1 trial -
Z-Brace interbody fusion device
Hospital Authority, Hong Kong
Cervical Disc Degeneration
1 trial -
Zaredrop 75 mg/ml soluzione orale, Laroxyl 40 mg/ml gocce orali soluzione, FLUOXETINA DOC Generici 20 mg/5 ml Soluzione orale, Zoloft 20 mg/ml concentrato per soluzione orale, Brintellix 20 mg/ml oral drops, solution, Daparox 33,1 mg/ml, gocce orali, soluzione., CITALOPRAM ABC 40 mg/ml gocce orali, soluzione, ESCITALOPRAM DOC 20 mg/ml gocce orali, soluzione
Verona Pharma Ireland Limited
Patients with currently remitted depressive disorders.
1 trial -
Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZΒ 300Β mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg
Disc Medicine
HIV-infected
1 trial -
[68Ga]FAPI-46
Disc Medicine
Peyronie's Disease
1 trial -
[68Ga]FAPI-46
Disc Medicine
Non-resolving ARDS
1 trial -
[68Ga]FAPI-46
Disc Medicine
post-acute sequelae of COVID-19
1 trial -
Adiposity and Iron Requirements in Pregnancy (ADIPREG)
Disc Medicine
Iron Deficiency Anemia of Pregnancy
1 trial -
Intravenous tramadol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Catheter Site Discomfort
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources